Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Shire, Vertex, BioMarin among firms lobbying Congress to maintain orphan drug tax credit in proposed tax reform
Shire, Vertex, BioMarin among firms lobbying Congress to maintain orphan drug tax credit in proposed tax reform
Shire, Vertex, BioMarin among firms lobbying Congress to maintain orphan drug tax credit in proposed tax reform
Submitted by
admin
on July 29, 2013 - 1:39pm
Source:
FT.com
News Tags:
Shire
Vertex Pharmaceuticals
Biomarin
orphan drugs
Orphan Drug Tax Credit
Headline:
Shire, Vertex, BioMarin among firms lobbying Congress to maintain orphan drug tax credit in proposed tax reform
Do Not Allow Advertisers to Use My Personal information
